Determinants of tubular bone marrow-derived cell engraftment after renal ischemia/reperfusion in rats  by Broekema, Martine et al.
Kidney International, Vol. 68 (2005), pp. 2572–2581
Determinants of tubular bone marrow–derived cell engraftment
after renal ischemia/reperfusion in rats
MARTINE BROEKEMA, MARTIN C. HARMSEN, JASPER A. KOERTS, ARJEN H. PETERSEN,
MARJA J.A. VAN LUYN, GERJAN NAVIS, and ELIANE R. POPA
Department of Pathology and Laboratory Medicine, Medical Biology Section, University Medical Center Groningen, Univerisity of
Groningen, The Netherlands; and Department of Nephrology, University Medical Center Groningen, University of Groningen,
The Netherlands
Determinants of tubular bone marrow–derived cell engraft-
ment after renal ischemia/reperfusion in rats.
Background. Ischemia/reperfusion (I/R) injury is a major
cause of acute renal failure (ARF). ARF is reversible, due to an
innate regenerative process, which is thought to depend partly
on bone marrow–derived progenitor cells. The significance of
these cells in the repair process has been questioned in view
of their relatively low frequency. Here, we hypothesize that the
severity of renal damage and the postischemic recovery time are
determinants of tubular bone marrow–derived cell (BMDC)
engraftment.
Methods. We used a model of unilateral renal I/R in F344
rats reconstituted with R26-human placental alkaline phos-
phatase (hPAP) transgenic bone marrow, in which we quantified
and characterized tubular BMDC engraftment with increasing
severity of damage and in time.
Results. After I/R injury, BMDC engrafted the tubular ep-
ithelium and acquired an epithelial phenotype. Tubular epithe-
lial BMDC engraftment increased with longer ischemic time,
indicating that tubular epithelial BMDC engraftment increases
with the severity of damage. The number of circulating progen-
itor cells doubled early after I/R injury and was followed by
a transient increase in tubular epithelial BMDC engraftment.
The latter positively correlated with morphological recovery of
the kidney over time.
Conclusion. The extent of tubular BMDC engraftment de-
pends on the severity of renal damage and follows a distinct
time course after I/R injury. Therefore, the severity of damage
and time course need to be taken into account when interpreting
data on the role of tubular BMDC engraftment in renal repair
after I/R injury.
Renal ischemia/reperfusion (I/R) injury is a major
cause of acute renal failure (ARF), a condition affecting
up to 5% of long-term hospital patients [1], and, addition-
ally, posing a potential postoperative problem for kidney
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transplant patients. Renal I/R injury is the result of oxy-
gen deprivation and the subsequent cumulative assaults
of the ensuing inflammatory reaction on renal vascular
and epithelial tissue.
Severe I/R injury is characterized by tubular epithelial
cell death and loss of kidney function [2]. Interestingly,
however, renal I/R injury is reversible [3], indicating that
innate repair mechanisms are activated upon renal dam-
age. One of these mechanisms is thought to involve bone
marrow–derived progenitor cells, which have been shown
to engraft affected kidneys and to adopt an epithelial
phenotype [4–7], possibly replacing damaged tubular ep-
ithelial cells. The functional significance of bone marrow–
derived cells (BMDCs) in renal repair is so far uncertain.
Whereas there are data to suggest a contribution to renal
repair, it has been pointed out that the number of BMDCs
detected in the kidney after I/R injury is low and variable,
typically ranging between just 2% and 8%, which led to
questioning their functional significance [5, 7].
The determinants of the extent of BMDC engraftment
have not been explored so far, which hampers the in-
terpretation of previous data. Here, we hypothesize that
the extent of BMDC engraftment is modulated by the
severity of renal damage and post-I/R injury recovery
time. Moreover, the impact of endogenous repair, based
on proliferation of surviving renal cells, was investigated.
While the impact of these three parameters on renal
BMDC engraftment has not yet been explored, they are
likely to play a role in renal repair. It is known, for ex-
ample, that increasing severity of I/R injury negatively
affects renal recovery. Furthermore, studies concerning
mobilization kinetics of endothelial progenitor cells after
acute myocardial infarction demonstrated a gradual in-
crease in numbers of these cells in the circulation, peak-
ing on day 7 postinfarction, suggesting the presence of
windows of opportunity for engraftment of these cells in
the heart [8]. Finally, proliferation of resident tubular ep-
ithelial cells that survive renal I/R injury is thought to
contribute to the restoration of kidney morphology and
function [9–11].
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The hypotheses were tested using a model of unilateral
renal I/R in F344 rats reconstituted with rat R26-human
placental alkaline phosphatase (hPAP) transgenic bone
marrow. The unilateral model, with the other kidney re-
maining in situ to ensure residual renal function and sur-
vival of the animals, allowed us to study not only mild and
moderate, but also severe I/R injury.
METHODS
Study design
In both experiments, unilateral renal ischemia was in-
duced in R26-hPAP → F344 bone marrow chimeric rats.
To investigate the influence of the severity of renal
damage on tubular BMDC engraftment we modulated
damage extent by varying ischemic times (20, 30, 45, and
60 minutes) (N = 3 per group). The effect of renal damage
extent on renal morphology was monitored after 7 days
by periodic acid-Schiff (PAS) staining, the effect on renal
function and tubular BMDC engraftment after 28 days.
To study the kinetics of tubular epithelial BMDC en-
graftment in relation to recovery time, we inflicted 45 min-
utes of unilateral ischemia and evaluated tubular BMDC
engraftment after 1 (N = 6), 3 (N = 6), 7 (N = 6), 14
(N = 7), 28 (N = 5), 56 (N = 3), and 112 (N = 3) days of
recovery.
Animals
Male, 6-week-old F344 rats (Harlan Nederland, Horst,
The Netherlands) were used as bone marrow recipients.
R26-hPAP rats (founders were a kind gift of Dr. E.
Sandgren; F344 background, 6-week-old), transgenic for
hPAP [12], were used as bone marrow donors.
Rats were housed in a conventional environment and
received standard chow and water ad libitum. Drink-
ing water was supplemented with 1 mg/mL 5-bromo-
2-deoxyurdine (BrdU) (Sigma Chemical Co., St. Louis,
MO, USA), for 3 days before termination.
All animal procedures were approved by the local
committee for care and use of laboratory animals and
performed according to governmental and international
guidelines on animal experimentation.
Irradiation and bone marrow transplantation
Nontransgenic rats received lethal total body irradia-
tion (9 Gy) (IBL 637 Cesium-137 c ray source) for bone
marrow ablation. Subsequently, the rats were housed in
filter top cages. Drinking water was supplemented with
neomycin (0.35% wt/vol) starting 1 week before irradia-
tion until 2 weeks after irradiation.
Total bone marrow from R26-hPAP rats was isolated
by flushing femurs and tibiae with sterile phosphate-
buffered saline (PBS). Erythrocytes were lysed in
155 mmol/L NH4Cl, 10 mmol/L KHCO3, 0.1 mmol/L
sodium ethylenediaminetetraacetic acid (EDTA), and
the bone marrow cell suspension was filtered through a
10 lm cell strainer (Falcon) (Becton Dickinson, Alphen
aan den Rijn, The Netherlands). Bone marrow isolation
was carried out on ice.
Twenty-four hours after irradiation, rats received ap-
proximately 1 × 106 R26-hPAP bone marrow cells intra-
venously and were allowed to recover for 4 weeks. Bone
marrow chimerism in recipients was determined by en-
zymatic hPAP staining (see below) on bone marrow cy-
tospots from recipients and was typically between 80%
and 90%.
Surgical procedure
Reconstituted bone marrow recipients were sedated by
general isoflurane (2% Forene) (Abbot b.v., Hoofddorp,
The Netherlands), N2O (50%), O2 (50%) anesthesia. The
left renal artery was exposed and clamped with a nontrau-
matic clamp to induce ischemia. The clamp was removed
after specified periods and renal reperfusion was con-
firmed visually. Sham-operated control rats underwent
bone marrow transplantation followed by a midline inci-
sion.
At specified time points after I/R, rats were anes-
thetized. Blood samples were drawn and both kidneys
were perfused in situ with cold saline. Kidneys were iso-
lated and divided into quarters by a longitudinal and a
transversal section. These quarters were fixed in zinc fixa-
tive (0.1 mol/L Tris buffer, pH 7.4, with 0.5 g CaCH2COO,
5 g (CH2COO)2 Zn ∗ 2 H2O, and 5 g ZnCl2 per L) (Merck,
Darmstadt, Germany), or snap-frozen in N2 and stored
at −80◦C. Zinc-fixed tissues were processed for paraf-
fin embedding by standard procedures and used for im-
munohistochemistry. Snap-frozen tissue was used for
immunofluorescence microscopy.
Kidney function
Plasma creatinine levels were determined using a col-
orimetric test (Merck MEGA Analyzer) (Merck).
Detection of lineage-negative (Lin−) cells
Mobilization of bone marrow–derived progenitor cells
to the circulation was determined using total mononu-
clear cell fractions. Since no monoclonal antibodies
specific for rat progenitor cell markers are available,
we assessed circulating Lin− cells as a population
enriched for potential bone marrow–derived progeni-
tor cells. Briefly, mononuclear cell fractions were iso-
lated by lympholite rat density gradient centrifugation
(Cederlane, Uden, The Netherlands). Mononuclear cells
were stained with a cocktail of polyethylene (PE) or
fluorescein isothiocyanate (FITC)-labeled monoclonal
antibodies against the lineage markers CD3 (T cells)
(Becton Dickinson), CD11b/c (myeloid and dendritic
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cells) (Becton Dickinson), and antirat j/k (B cells)
(Sigma-Aldrich, Zwijndrecht, The Netherlands). Lin−
cells were detected and quantified on day 1 (N = 3), 3
(N = 3), 7 (N = 3), and 14 (N = 3) after 45 minutes
of ischemia using MoFlo cytometer (Cytomation Inc.,
Fort Collins, CO, USA), and WinList 5.0 software (Verity,
Topsham, ME, USA).
(Immuno)histochemistry
Enzymatic hPAP staining was used to detect renal infil-
tration of hPAP+ BMDCs. Briefly, 5 lm paraffin sections
were dewaxed and endogenous alkaline phosphatase
was heat-inactivated by incubation in substrate buffer
(0.1 mol/L Tris-HCl, pH 9.5, 0.1 mol/L NaCl, and
5 mmol/L MgCl2) at 65◦C for 30 minutes [12]. Sub-
sequently, sections were incubated in fresh substrate
buffer containing 2% (vol/vol) nitroblue tetrazolium/5-
bromo-4-chloro-3-indolyl phosphate (NBT/BCIP)
(Roche, Woerden, The Netherlands) (5 hours, room
temperature).
Detection of hPAP+ BMDCs was confirmed by im-
munohistochemical staining using a rabbit anti-hPAP
antibody (Serotec, Oxford, UK) to detect bone marrow–
derived cells. Briefly, 5 lm zinc-fixed paraffin sec-
tions were dewaxed and subjected to endogenous
alkaline phosphatase inactivation by incubation in sub-
strate buffer at 65◦C for 30 minutes [12]. Nonspe-
cific protein binding was blocked with 2% bovine
serum albumin (BSA) for 30 minutes and endoge-
nous biotin was blocked with biotin blocking kit (Bi-
otin Blocking System) (Dako, Glostrup, Denmark).
Rabbit anti-hPAP antibody was applied to the sec-
tions for 60 minutes, at room temperature, followed
by biotinylated goat antirabbit conjugate (Dako), and
streptavidin-alkaline phosphatase (Southern Biotechno-
logy, Birmingham, AL, USA). Color development was
performed with Fuchsin Substrate-Chromogen System
according to manufacturer’s instructions (Dako).
The epithelial phenotype of tubular engrafted BMDCs,
was assessed by immunofluorescent double-staining
for hPAP (rabbit-antihPAP) in combination with, re-
spectively, E-cadherin (clone 36) (Becton Dickinson
Biosciences), pan-cytokeratin (C-11) (Abcam, Cam-
bridgeshire, UK), or a cocktail of the tubular epithelial-
specific lectins: SBA (biotinylated soybean agglutinin),
DBA (biotinylated Dolichos biﬂorus agglutinin), and
PNA (biotinylated peanut agglutinin) (all from Vector
Laboratories Inc., Burlingame, CA, USA). Briefly, on
5 lm cryosections, endogenous biotin was blocked with
biotin blocking kit (Biotin Blocking System) according
to manufacturer’s instructions (Dako). BMDCs were
detected by incubation with anti-hPAP (1 hour, room
temperature), followed by goat antirabbit-FITC conju-
gate (Southern Biotechnology). Tubular epithelial cells
were detected in several ways; by incubation with a
mixture of 30 lg/mL biotinylated SBA/DBA/PNA fol-
lowed by a streptavidin-Cy3 (Zymed Laboratories Inc.,
San Francisco, CA, USA) conjugate, or by incubation
with monoclonal antibodies against E-cadherin and pan-
cytokeratin (1 hour, room temperature) followed by bi-
otinylated goat antimouse (IgG2a for E-cadherin and
IgG1 for pan-cytokeratin) (Dako) and streptavidin-Cy3
conjugates (Zymed Laboratories Inc.).
To confirm that hPAP+ cells, engrafted in renal tubuli,
were not engrafted bone marrow–derived leukocytes, we
performed double-staining combining hPAP with CD45
(leukocyte marker). Briefly, on 5 lm cryosections, en-
dogenous biotin was blocked and BMDCs were detected
as described above. Leukocytes were detected by incu-
bation with mouse antirat CD45 monoclonal antibody
(1 hour, room temperature) (OX-1, culture supernatant),
followed by biotinylated goat antimouse IgG (Southern
Biotechnology) and streptavidin-Cy3 conjugates (Zymed
Laboratories Inc.).
To detect BrdU incorporation, 5 lm paraffin sections
were treated with 0.7 mol/L HCl (30 minutes, 37◦C),
followed by incubation with 0.025% (wt/vol) pepsin in
0.35 mol/L HCl (15 minutes, 37◦C) (Roche). BrdU was
detected by incubation with anti-BrdU monoclonal anti-
body (1 hour, room temperature) (Sigma-Aldrich), fol-
lowed by biotinylated goat antimouse IgG (Southern
Biotechnology) and streptavidin-conjugated peroxidase
(Dako). Color development was performed with 3-
amino-9-ethylcarbazole (Sigma-Aldrich) substrate dis-
solved in N,N-dimethylformamide (Merck) and 0.5 mol/L
acetate buffer, pH 4.9.
All conjugate incubations were performed for 30 min-
utes at room temperature, in the dark, and were followed
by appropriate washing steps. Immunofluorescence sec-
tions were counterstained with DAPI and mounted with
citifluor (Agar Scientific, Stansted, UK). Immunohis-
tochemically stained sections were counterstained with
Mayer’s hemalum (Merck) and mounted in Kaiser’s glyc-
erol (Merck).
Light and fluorescence microscopy was performed us-
ing a Leica DMLB microscope (Leica Microsystems,
Rijswijk, The Netherlands), Leica DC300F camera, and
Leica QWin 2.8 software. To confirm that double positive
cells were not the result of overlying cells, confocal mi-
croscopy was performed using a Leica TCS SP2 confocal
microscope and Leica confocal 2.5 software.
Quantification
The severity of morphologic renal damage was assessed
using an arbitrary score based on PAS-stained kidney
sections. Briefly, the extent of four typical I/R injury–
associated damage markers (i.e., dilatation, denudation,
intraluminal casts, and cell flattening) was expressed in
arbitrary units (AU) in a range of 0 to 3.
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Fig. 1. Morphologic kidney damage extent
in relation to ischemic time. Representative
morphology of a healthy control kidney (A)
and of kidneys subjected to 30 (B), 45 (C), and
60 minutes of ischemia (D) assessed on day 7
after ischemia/reperfusion (I/R) injury induc-
tion by periodic acid-Schiff (PAS) staining of
paraffin sections. Arrows indicate examples of
tubular membrane denudation. Asterisks in-
dicate examples of intraluminal casts (magni-
fication 200×).
Tubular engraftment of BMDCs in the cortex and outer
medulla was assessed by scoring the number of tubulus
sections containing at least one hPAP+ cell. To be consid-
ered an epithelial cell, hPAP+ cells had to be integrated
in the renal tubule at the luminal side of the basal mem-
brane and have epithelial size and morphology, similar to
that of neighboring, resident tubular cells. Kidney section
area was determined by computerized planimetry (Leica
QWin 2.8 software) and differences in kidney section area
were corrected for by expressing the number of hPAP+
tubuli per 10 mm2.
The percentage of the tubular engrafted BMDCs which
also express a tubular epithelial marker was determined
on kidney sections after immunofluorescence staining for
hPAP and a tubular epithelial marker.
To determine proliferation-mediated renal repair in
the cortex and outer medulla, we first determined the per-
centage of tubulus sections containing at least one BrdU+
cell. Subsequently, the percentage of BrdU+ nuclei per
BrdU+ tubulus section was determined.
Statistics
Statistical tests were performed using GraphPad Prism
4.0 (GraphPad Software, San Diego CA, USA) and SPSS
12.0 software (SPSS Inc., Chicago, IL, USA). Two-tailed
Mann-Whitney U tests were performed to determine dif-
ferences between sham and experimental groups. Spear-
man correlation tests were performed to determine the
relationship between different parameters. P values <
0.05 were considered statistically significant.
RESULTS
Morphologic and functional damage extent in relation to
ischemic time
On day 7, morphologic I/R injury was observed in the
tubular epithelium in cortex and outer medulla, while
glomeruli were morphologically normal. Increasing is-
chemic time was associated with increasing renal dam-
age (Fig. 1B to D), as apparent from the presence of all
classic damage markers, such as proximal epithelial cell
flattening or loss, tubular dilatation, and the intralumi-
nal brush border debris and protein casts [13]. Tubular
denudation was observed after 45 minutes of ischemia
(Fig. 1C). Sixty minutes of ischemia resulted in extensive
damage (Fig. 1D) and was not further investigated.
The cumulative damage score, assessed on day 28 af-
ter 20, 30, and 45 minutes of ischemia, was higher in the
groups with longer ischemic time, thereby validating our
model (Fig. 2A). The cumulative damage score signifi-
cantly correlated with ischemic time (Fig. 2B). Plasma
creatinine levels, assessed on day 28 after 20, 30, and
45 minutes of ischemia, were slightly but significantly
higher than in sham controls (Fig. 2C).
Tubular epithelial BMDC engraftment in relation
to ischemic time
hPAP was ubiquitously expressed in renal cells of R26-
hPAP transgenic rats (Fig. 3A), and was undetectable
in nontransgenic kidneys (not shown) and in postis-
chemic kidneys of nonbone marrow–transplanted F344
rats (Fig. 3B). In ischemic kidneys of R26-hPAP bone
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Fig. 2. Morphologic and functional kidney damage extent in relation
to ischemic time. Severity of damage was determined by an arbitrary
score of the presence of four typical ischemia/reperfusion (I/R) injury–
associated damage markers (i.e., dilatation, denudation, intraluminal
casts, and cell flattening) and expressed in arbitrary units in a range
of 0 to 3. The severity of damage was assessed on periodic acid-Schiff
(PAS)–stained kidney sections of rats sacrificed on day 28 after 20, 30,
and 45 minutes of ischemia (A). Correlation between damage score
and ischemic time was assessed by a Spearman correlation test (B).
Sham-operated controls (◦), 20 minutes of ischemia (), 30 minutes of
ischemia (), and 45 minutes of ischemia (•). Plasma creatinine lev-
els were measured on day 28 after 20, 30, and 45 minutes of ischemia
(C). Bars indicate mean + SEM of all experimental animals per group.
∗P < 0.05; ∗∗P < 0.005, statistically significant differences compared to
sham.
marrow–transplanted rats, most hPAP+ BMDCs formed
interstitial infiltrates (Fig. 3C). On day 28 after I/R injury
induction, the extent of renal BMDC infiltration was sim-
ilar in kidneys subjected to 20 and 30 minutes of ischemia,
but more extensive in kidneys subjected to 45 minutes of
ischemia (not shown). Morphologic examination of the
contralateral kidney demonstrated small interstitial infil-
trates of hPAP+ BMDCs (not shown).
To determine tubular epithelial BMDC engraftment
we sought for hPAP+ cells that were integrated in the
renal tubulus, at the luminal side of the basal membrane
(Fig. 3D). hPAP+ expression was confirmed by immuno-
histochemical staining on consecutive slides (Fig. 3E).
Typically, in engrafted tubuli, we detected one hPAP+
cell per tubulus section and, sporadically, two or three,
but never more. In sham-operated and contralateral kid-
neys, BMDC-engrafted tubuli were infrequent and sig-
nificantly lower compared to ischemic kidneys (Fig. 3F).
After ischemia, the number of BMDC-engrafted tubuli
in cortex and outer medulla increased progressively with
ischemic time (Fig. 3F) and, moreover, correlated signif-
icantly with ischemic time (Fig. 3G).
Epithelial phenotype of BMDC engrafted in tubuli
The epithelial phenotype of engrafted hPAP+ cells was
assessed by immunofluorescence double-staining com-
bining hPAP detection with detection of the epithelial
markers E-cadherin, pan-cytokeratin, and epithelial-
binding lectins (SBA, DBA, and PNA). In accor-
dance with the enzymatic detection of tubular engrafted
BMDCs, engrafted tubuli contained one or two hPAP+
cells. These cells also bound lectins (Fig. 4A to C), or co-
expressed pan-cytokeratin (Fig. 4D to F) or E-cadherin
(Fig. 4G to I). Independently of the epithelial marker
used, an average of 94% of the tubular engrafted BMDCs
also expressed a tubular epithelial marker. Neither E-
cadherin nor pan-cytokeratin expression or epithelial
lectin binding was observed within hPAP+ inflammatory
cell infiltrates, indicating the specificity of these tubular
epithelial markers (not shown).
To confirm that tubular epithelial engrafted BMDCs
were not incorporated leukocytes, we performed a
double-staining combining hPAP with CD45 (leukocyte
marker). Cells expressing CD45 were only present in in-
terstitial infiltrates, but were not engrafted in the tubular
epithelium (Fig. 4J to L).
Tubular epithelial BrdU incorporation in relation with
ischemic time
The extent of proliferation in tubular epithelial cells in
the cortex and outer medulla was assessed by BrdU incor-
poration into nuclei of tubular epithelial cells on day 28
after I/R injury induction. No differences in BrdU incor-
poration, quantified as the percentage of BrdU+ tubuli
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Fig. 3. Tubular epithelial bone marrow–derived cell (BMDC) engraft-
ment in relation to ischemic time. To detect human placental alka-
line phosphatase (hPAP+) (i.e., bone marrow–derived cells), enzymatic
staining of hPAP was performed after heat inactivation of endogenous
alkaline phosphatase. Ubiquitous expression of hPAP was observed
in R26-hPAP transgenic rat kidney (A). hPAP staining was absent in
postischemic kidneys of nonbone marrow–transplanted F344 rats (B).
Expression of hPAP was observed on infiltrating BMDC in postischemic
kidneys of rats, reconstituted with R26-hPAP transgenic bone marrow
(C) (magnification 400×). Engraftment of hPAP+ cells in tubuli of is-
chemic kidney was observed on day 28 after 45 minutes of ischemia with
enzymatic hPAP staining (D) and was confirmed by immunohistochem-
ical hPAP staining on a consecutive slide (E). Note similar morphology
of hPAP+ cells to that of neighboring, resident tubular cells. Arrows
indicate examples of tubular epithelial BMDC engraftment (magnifi-
cation 1000×). Tubular BMDC engraftment in relation to damage ex-
tent was determined on day 28 after ischemia/reperfusion (I/R) injury
induction (F). Tubulus sections containing at least one hPAP+ cell with
epithelial morphology were counted in the cortex and outer medulla.
Scoring was performed on sham (), contralateral ( ), and ischemic kid-
neys (). Bars indicate mean values + SEM of all experimental animals
per group. ∗P < 0.05; ∗∗P < 0.005, statistically significant differences
compared to sham. Correlation between tubular BMDC engraftment
FITC
hPAP
Cy3
epithelial marker Overlay
Lectins
Pan-
cytokeratin
E-cadherin
FITC
hPAP
Cy3
CD45 Overlay
A B C
D E F
G H I
J K L
Fig. 4. Epithelial phenotype of bone marrow–derived cells (BMDCs)
engrafted in tubuli. Epithelial phenotype of BMDCs engrafted in tubuli
after ischemia/reperfusion (I/R) injury was confirmed by immunofluo-
rescence codetection of human placental alkaline phosphatase (hPAP)
(A, D, and G) and epithelium-binding lectins SBA (biotinylated soy-
bean agglutinin), DBA (biotinylated Dolichos biﬂorus agglutinin), and
PNA (biotinylated peanut agglutinin) (cocktail) (B) or the epithelium-
specific markers pan-cytokeratin (E) and E-cadherin (H). Double-
positive cells are shown in the overlay pictures (C, F, and I). To confirm
that tubular engrafted BMDCs were not leukocytes we used immunoflu-
orescence codetection of hPAP (J) and CD45 (K) (common leukocyte
antigen). No double-positive cells were found engrafted in the tubu-
lar epithelium (L, overlay). Green color is fluorescein isothiocyanate
(FITC), red is Cy3, blue is DAPI. Arrows indicate examples of tubular
engrafted BMDC. Note identical morphology of positive cells in both
channels (magnification 400×).
and as the percentage of BrdU+ nuclei per BrdU+ tubu-
lus section, were present between sham, contralateral,
and postischemic kidneys. In all cases, most BrdU+ nu-
clei were found within the tubular epithelium and often
appeared in pairs. Sporadically, proliferating cells were
present in the tubulointerstitial spaces and in glomeruli
(not shown).
and ischemic time was assessed by a Spearman correlation test (G).
Sham-operated controls (◦), 20 minutes of ischemia (), 30 minutes of
ischemia (), and 45 minutes of ischemia (•).
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Fig. 5. Time course of morphologic and func-
tional kidney regeneration. Representative
morphology of a kidney subjected to 45 min-
utes of ischemia on day 1 (A) and day 112
(B) after ischemia/reperfusion (I/R) injury in-
duction, was assessed by periodic acid-Schiff
(PAS) staining of paraffin sections. Arrows
indicate examples of tubular membrane de-
nudation. Asterisks indicate examples of in-
traluminal casts (magnification 200×). The
severity of damage was determined by an arbi-
trary score, ranging from 0 to 3 arbitrary units
(a.u.), of 4 classic damage markers present in
PAS-stained kidney sections (C). Plasma cre-
atinine levels were assessed to determine kid-
ney function (D). Bars indicate mean levels +
SEM of all experimental animals per group.
∗P < 0.05; ∗∗P < 0.005; ∗∗∗P < 0.0005, sta-
tistically significant differences compared to
sham.
Time course of morphologic and functional kidney
regeneration
To study the time course of renal repair, the ischemic
time of 45 minutes was selected, since this model yielded
sufficient renal damage, especially in terms of tubular de-
nudation, but still allowed for regeneration.
On day 1, extensive epithelial cell loss in the cortex
and outer medulla was observed (Fig. 5A). By day 112,
the tubular epithelium was virtually restored and is-
chemic damage markers, discussed above, were atten-
uated (Fig. 5B). Cumulative severity of damage score
showed a gradual morphologic recovery in time (Fig. 5C).
Plasma creatinine levels peaked slightly, but significantly,
on day 1, with a gradual decrease toward baseline values
afterward (Fig. 5D).
Time course of mobilization of BMDCs
Tubular epithelial BMDC engraftment is preceded by
mobilization of bone marrow–derived progenitor cells to
the circulation. After a reduction on day 1 after I/R in-
jury, the number of circulating Lin− cells, a population
enriched for progenitor cells (Fig. 6A), increased and
peaked on day 3, compared to controls (Fig. 6B). After
day 3, the number of Lin− cells gradually decreased and
reached control values by day 14.
Time course of tubular epithelial BMDC engraftment
The majority of infiltrating BMDCs formed interstitial
infiltrates. The infiltrate size peaked by day 7 and grad-
ually decreased after day 14. Small interstitial infiltrates
persisted in the kidney until day 112 (not shown).
In engrafted tubuli, typically one hPAP+ cell was
present per BMDC-engrafted tubulus section. On days
1 and 3 after ischemia, BMDC-engrafted tubuli were in-
frequent and comparable in number to tubular BMDC
engraftment in sham and contralateral kidneys (Fig. 6C).
On day 7, a sharp increase in the number of BMDC-
engrafted tubuli was observed, followed by a peak on
day 14, gradually decreasing by days 28 and 56, to return
to sham levels on day 112 (Fig. 6C).
The epithelial phenotype of hPAP+ cells engrafted
in tubuli was confirmed as above. Immunofluores-
cence double-staining combining hPAP detection with
detection of the epithelial markers E-cadherin, pan-
cytokeratin, and epithelial-binding lectins (SBA, DBA,
and PNA) was in agreement with the peak of tubular ep-
ithelial BMDC engraftment on day 14 and low frequency
on day 56 and 112 after I/R injury induction. Over time
we observed, independently of tubular epithelial marker,
a slight increase in the percentage of tubular engrafted
BMDCs which also expressed a tubular epithelial marker
(91 ± 5% on day 7, 93 ± 2% on day 14, and 97 ± 2% on
day 28).
Time course of tubular epithelial BrdU incorporation
Most BrdU+ nuclei in cortex and outer medulla were
found in the tubular epithelium. In sham kidneys typi-
cally one, and sporadically, two BrdU+ nuclei per tubulus
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Fig. 6. Time course of recruitment of bone marrow–derived cells
(BMDCs) to the circulation and the kidney. Circulating lineage-
negative (Lin−) cells (gated) were detected by flow cytometry after
staining of mononuclear cells with monoclonal antibodies against the
lineage markers CD3 and CD11b/c [both polyethylene (PE)-labeled]
and antirat j/k [fluorescein isothiocyanate (FITC)-labeled] (A) and
quantified at various time points after 45 minutes of ischemia (B). Tubu-
lar BMDC engraftment was assessed as the number of tubuli containing
at least one human placental alkaline phosphatase positive (hPAP+)
epithelial cell by enzymatic staining for the hPAP enzyme (C). hPAP+
tubuli were scored in the cortex and outer medulla of sham (), con-
tralateral ( ), and ischemic () kidneys. Bars indicate mean values +
SEM of all experimental animals per group. Ctrl is control and S is
sham. ∗P < 0.05; ∗∗P < 0.005.
section were observed (Fig. 7A), in ischemic kidneys, fre-
quently three or more adjacent BrdU+ tubular epithelial
cells were detected (Fig. 7B), with the highest frequency
on day 7 after I/R injury.
The extent of BrdU incorporation was quantified as the
percentage of BrdU+ tubuli (Fig. 7C) and as the percent-
age of BrdU+ nuclei per BrdU+ tubulus section (Fig. 7D).
The percentage of BrdU+ tubuli dropped significantly
early after I/R injury to recover to control values from
day 7 on. The percentage of BrdU+ nuclei per BrdU+
tubule was difficult to determine on days 1 and 3 due to ex-
tensive tubular denudation and, therefore, absence of nu-
clei. As a result, not all experimental animals from these
time points could be included in the quantification. The
percentage of BrdU+ nuclei per BrdU+ tubule peaked
on day 7 and decreased to control values afterwards.
DISCUSSION
The current study demonstrates that the severity of re-
nal damage is an important modulator of the extent of
tubular epithelial BMDC engraftment after I/R injury
in rats. Moreover, BMDC engraftment follows a distinct
time course, different from the time course of prolifera-
tion of tubular epithelial cells.
To detect the bone marrow origin of tubular engrafted
cells, we used the rat R26-hPAP transgene as a reporter
marker. hPAP is one of the few available rat reporter
markers and is more reliable than other commonly used
reporter molecules, such as GFP and b-galactidase (b-
gal). Problems with differential expression in kidney cells,
as encountered with renal GFP expression in mice [14],
or activation of endogenous protein expression at low pH
(e.g., mammalian b-gal expression) [abstract; Duffield JS
et al, J Am Soc Nephrol 15:38A, 2004) were not encoun-
tered when using hPAP as a reporter marker.
We modulated the severity of renal damage by ex-
posing the kidneys to different ischemic times. Thus, as
apparent from the morphologic data, a gradient in the
severity of renal damage was obtained that ranged from
relatively moderate in the 20-minute group to severe
in the 45-minute group. As the contralateral kidney re-
mained in situ, the acute tubular necrosis did not result
in severe acute renal insufficiency, as apparent from the
mild rise in plasma creatinine. This allowed the animals
to survive the period of acute tubular necrosis, and thus
enabled us to study the renal recovery after severe I/R
injury. Whereas the time course of plasma creatinine cor-
responded to the morphologic restoration of the kidney,
the contribution of the contralateral kidney to overall
renal function precludes conclusions on the functional
recovery of the ischemic kidney.
The relationship between the severity of renal damage
and extent of tubular BMDC engraftment suggests that
the extent of engraftment is determined by increasing
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Fig. 7. Time course of tubular epithelial 5-
bromo-2-deoxyurdine (BrdU) incorporation.
Single BrdU+ nuclei (black) were typically
present in tubuli of sham kidneys (A). Mul-
tiple BrdU+ nuclei were present within tubu-
lar epithelial cells in ischemic kidneys 7 days
after ischemia/reperfusion (I/R) injury (B)
(magnification 1000×). To determine the ex-
tent of proliferative tubular repair we first
determined the percentage of BrdU+ tubuli
in cortex and outer medulla (C). Second, we
determined the percentage of BrdU+ tubu-
lar epithelial cells in 10 tubuli in the cor-
tex and 10 tubuli in the outer medulla (D).
BrdU incorporation in ischemic kidney was
compared with incorporation in correspond-
ing sham kidneys at the respective time point.
Bars indicate mean values + SEM of all exper-
imental animals per group. ∗P < 0.05; ∗∗∗P <
0.0005.
need for repair. The mechanism underlying the relation-
ship between the severity of damage and tubular BMDC
engraftment was not addressed in our study. However,
we propose that the presence and amount of molecular
repair mediators in the postischemic renal niche is influ-
enced by the severity of damage, thereby influencing the
extent of BMDC engraftment.
Documentation of the time course of tubular BMDC
engraftment after I/R injury was the second purpose of
our study. We first studied the time course of mobiliza-
tion of bone marrow–derived progenitor cells to the cir-
culation. In accordance with data by Kale et al [4], we
observed an early increase in the number of circulating
Lin− cells after I/R injury induction, indicating a rela-
tionship between renal damage and recruitment of bone
marrow–derived progenitor cells to the circulation. Num-
bers of circulating Lin− cell peaked on day 3 after I/R
injury. A lag between injury and maximal recruitment of
progenitor cells to the circulation was also reported in pa-
tients with acute myocardial infarction by Shintani et al
[8], who found a peak of circulating endothelial progen-
itor cells on day 7 after the ischemic event. The gradual
decrease in numbers of circulating Lin− cells, observed
from day 7 after I/R injury induction on, would be com-
patible with homing of these cells to the damaged kid-
ney. The appearance of bone marrow–derived interstitial
infiltrates in the kidney by day 7 supports this scenario.
Moreover, the number of engrafted BMDCs with epithe-
lial phenotype also increased on day 7, demonstrating
specific differentiation of some of the infiltrating cells to
tubular epithelium. A slight increase in the percentage
of tubular engrafted BMDCs coexpressing a tubular ep-
ithelial marker was observed in time, indicating that dif-
ferentiation of these cells upon arrival is not immediate.
The long-term follow-up in our study, with follow-up
data up to 112 days after I/R injury, allowed us to inves-
tigate tubular epithelial BMDC engraftment during the
complete time course of the tubular epithelial restora-
tion process of the kidney after I/R injury. An interesting
finding was the decline in numbers of bone marrow–
derived tubular epithelial cells at long-term follow-up.
An explanation for this phenomenon may be turnover,
during which tubular engrafted BMDCs may be replaced
by nonbone marrow–derived renal cells, resulting in dis-
appearance of the hPAP signal. However, since it was
not technically feasible to perform double staining for
hPAP and BrdU, it remains unclear whether tubular en-
grafted BMDCs underwent proliferation in the kidney.
Furthermore, it is conceivable that the presence of proper
growth factors and adhesion molecules in the ischemic
niche would be responsible for creating a compatible sit-
uation for tubular epithelial BMDC engraftment and dif-
ferentiation. Thus, inadequacy or absence of these factors
could lead to loss of bone marrow–derived tubular ep-
ithelial cells.
Recently, it has been suggested that BMDC engraft-
ment may be the result of a spontaneous cell fusion pro-
cess, thereby questioning the biological relevance of stem
cell plasticity [15, 16]. In our study we are not able to dis-
tinguish cell transdifferentiation from cell fusion and are,
therefore, unable to rule out the possible contribution of
cell fusion to tubular BMDC engraftment. Cell fusion,
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followed by reprogramming of the fusion product and si-
lencing of the hPAP gene, could be a cause for the decline
in tubular epithelial BMDC engraftment we observed at
later postischemic time points.
Our data are in agreement with previous studies report-
ing low numbers of tubular BMDC engraftment in mouse
models of renal ischemia [5, 7, 17]. Together with the de-
cline in their numbers at long term follow-up, this could
be taken to argue against a functional role of BMDCs
in tubular epithelial cell replacement. However, it has
recently been shown that, when activated by proinflam-
matory cytokines in vitro, CD34+ bone marrow–derived
progenitor cells express a variety of immunoregulatory
mediators, thereby exerting a potential modulatory role
in their environment [18]. Thus, even at low numbers,
bone marrow–derived tubular epithelial cells might have
functional significance during the process of renal repair,
but further studies are needed to substantiate this issue.
The overall low frequency of tubular BMDC engraft-
ment in the ischemic kidney and the occurrence of com-
plete tubular reepithelialization indicate that, besides
BMDC engraftment, another mechanism must be in-
volved in the repopulation of the denuded tubular mem-
branes. Renal repair most likely occurs as a concerted
process involving both tubular engraftment of BMDCs
and the proliferative activity of surviving renal cells. In-
deed, epithelial proliferation increased after I/R injury
and peaked on day 7, illustrating proliferation-mediated
tubular repair. Interestingly, the peak in epithelial pro-
liferation preceded that of tubular epithelial BMDC en-
graftment, which peaked on day 14 post-I/R injury. Thus,
tubular reepithelialization by proliferation appears to
be a distinct process with a different time course. In
fact, tubular reepithelialization was already ongoing by
the time of emerging tubular epithelial BMDC engraft-
ment, possibly explaining the low number of engrafted
BMDCs.
CONCLUSION
We showed that the extent of tubular epithelial BMDC
engraftment depends on the severity of damage, and fol-
lows a distinct time course after I/R injury induction.
Tubular reepithelialization by proliferation of renal cells
appeared to be a distinct process with a different time
course, already ongoing by the time of emerging tubular
epithelial BMDC engraftment. Thus, the severity of renal
damage, the time course and the contribution of prolifer-
ation to renal repair, need to be taken into account when
interpreting data on the role of tubular BMDC engraft-
ment in renal repair after I/R injury.
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